Equities
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)106.30
  • Today's Change0.00 / 0.00%
  • Shares traded197.17k
  • 1 Year change+1.24%
  • Beta0.6255
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,2971,104785
OPERATING EXPENSES
Cost of revenue total346302202
Selling, general and admin. expenses, total399358233
Depreciation/amortization6.235.184.36
Unusual expense(income)--(0.16)(0.1)
Other operating expenses, total(0.35)00.37
Total operating expense853742531
Operating income443361254
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes469448253
Provision for income taxes1037456
Net income after taxes365374196
Minority interest000
Net income before extra. Items365374196
Total extraordinary items------
Net income365374196
Inc.avail. to common excl. extra. Items365374196
Inc.avail. to common incl. extra. Items365374196
EPS RECONCILIATION
Basic/primary weighted average shares101101101
Basic/primary eps excl. extra items3.623.701.94
Basic/primary eps incl. extra items3.623.701.94
Dilution adjustment------
Diluted weighted average shares101101101
Diluted eps excl. extra items3.623.701.94
Diluted eps incl. extra items3.623.701.94
COMMON STOCK DIVIDENDS
DPS - common stock primary issue6.902.901.45
Gross dividend - common stock697293301
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.810.570.74
SUPPLEMENTAL INCOME
Depreciation, supplemental252225
Total special items3.684.9517
NORMALISED INCOME
Normalized income before taxes473453270
Effect of special items on income taxes0.810.823.85
Income tax excluding impact of special items1047560
Normalized income after tax368378210
Normalized income avail. to common368378210
Basic normalized EPS3.653.742.08
Diluted normalized EPS3.653.742.08
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.